Information for "Methodical Assessment along with MetaAnalysis involving Tocilizumab Treatments as opposed to Common of Treatment within around 20500 COVID19 Pneumonia Individuals throughout the First 8 Weeks of the Crisis"
From EECH Central
Basic information
| Display title | Methodical Assessment along with MetaAnalysis involving Tocilizumab Treatments as opposed to Common of Treatment within around 20500 COVID19 Pneumonia Individuals throughout the First 8 Weeks of the Crisis |
| Default sort key | Methodical Assessment along with MetaAnalysis involving Tocilizumab Treatments as opposed to Common of Treatment within around 20500 COVID19 Pneumonia Individuals throughout the First 8 Weeks of the Crisis |
| Page length (in bytes) | 3,532 |
| Page ID | 1411708 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Saladmass6 (Talk | contribs) |
| Date of page creation | 17:57, 27 April 2024 |
| Latest editor | Saladmass6 (Talk | contribs) |
| Date of latest edit | 17:57, 27 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
